What is it about?
Screening people with diabetes for asymptomatic coronary heart disease has not universally been shown yet to be beneficial or cost-effective and is not recommended. This paper reviews the studies that have examined the matter and gives future perspective.
Featured Image
Why is it important?
A lot of resources and time is spent on screening that has not been found to be beneficial and can even be harmful at times
Perspectives
It discourages screening, especially in view of the upcoming ISCHEMIA study results
Konstantinos Makrilakis
National and Kapodistrian University of Athens
Read the Original
This page is a summary of: Cardiovascular Screening for the Asymptomatic Patient with Diabetes: More Cons Than Pros, Journal of Diabetes Research, January 2017, Hindawi Publishing Corporation,
DOI: 10.1155/2017/8927473.
You can read the full text:
Contributors
The following have contributed to this page
